advanced microbiome therapeutics
Showing 1 - 25 of >10,000
Chemotherapy-Induced Nausea in Genitourinary Cancer and Changes
Not yet recruiting
- Bladder Cancer
- +2 more
- Blood and Tissue
-
Jacksonville, Florida
- +2 more
Apr 6, 2023
Head and Neck Squamous Cell Carcinoma Trial in Toronto (MET-4)
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jan 8, 2023
Serial Gut Microbiome and Bacterial Gene Markers Changes After
Recruiting
- Colorectal Cancer
- +2 more
- Bacterial gene markers test
-
Shatin, New Territories, Hong KongPrince of Wales Hospital
Oct 19, 2022
Gut and Tumor Microbiome in Advanced ER-positive and
Not yet recruiting
- Breast Cancer
- Melanoma
- Observation
- (no location specified)
Nov 6, 2023
Endometrial Cancer Trial in Houston (DKN-01, Pembrolizumab)
Not yet recruiting
- Endometrial Cancer
-
Houston, TexasM D Anderson Cancer Center
Feb 27, 2023
Superlean Individuals Including Gut Microbiome
Not yet recruiting
- Thinness
- Health Behavior
- Observation without intervention
-
Shenzhen, ChinaShenzhen Institute of Advanced Technology,
Mar 27, 2023
Metastatic Melanoma Trial in United States (Placebo for antibiotic, Vancomycin pretreatment, Nivolumab)
Completed
- Metastatic Melanoma
- Placebo for antibiotic
- +4 more
-
Los Angeles, California
- +6 more
Jun 7, 2022
AADC/TDC in Advanced Parkinson's Disease
Not yet recruiting
- Parkinson Disease
- (no location specified)
Dec 9, 2022
Rheumatoid Arthritis Trial in London (Etanercept, tofacitinib)
Recruiting
- Rheumatoid Arthritis
-
London, Ontario, CanadaRheumatology Clinic, St. Joseph's Health Care
May 10, 2022
Healthy Trial in Philadelphia (Standardized meal with a glucose challenge test)
Active, not recruiting
- Healthy
- Standardized meal with a glucose challenge test
-
Philadelphia, PennsylvaniaInstitute for Translational Medicine and Therapeutics (ITMAT), U
Dec 10, 2021
Head Neck Cancer Trial in Tampa (Prolonged Nightly Fasting, Regular Eating pattern)
Recruiting
- Head and Neck Cancer
- Prolonged Nightly Fasting
- Regular Eating pattern
-
Tampa, FloridaMoffitt Cancer Center
Jan 24, 2023
Mesothelin-positive Advanced Malignant Solid Tumors Trial (Anti-mesothelin CAR-T cells)
Not yet recruiting
- Mesothelin-positive Advanced Malignant Solid Tumors
- Anti-mesothelin CAR-T cells
- (no location specified)
Mar 13, 2023
Chronic Kidney Diseases, Pruritus Trial (Difelikefalin 1 mg Oral Tablet, Placebo Oral Tablet)
Recruiting
- Chronic Kidney Diseases
- Pruritus
- Difelikefalin 1 mg Oral Tablet
- Placebo Oral Tablet
-
Northridge, California
- +5 more
Dec 21, 2022
CD70-positive Advanced Urologic Tumors Trial in Shanghai (Anti-CD70 CAR-T cells)
Recruiting
- CD70-positive Advanced Urologic Neoplasms
- Anti-CD70 CAR-T cells
-
Shanghai, Shanghai, ChinaChanghai Hospital
Aug 11, 2023
Breast Cancer Trial in Little Rock (Blood & Fecal Collection)
Terminated
- Breast Cancer
- Blood & Fecal Collection
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
Jan 19, 2022
Advanced Lung Cancer Trial in Hangzhou (WTX212A injection)
Not yet recruiting
- Advanced Lung Cancer
- WTX212A injection
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Oct 27, 2023
Chronic Kidney Diseases, Pruritus Trial (Difelikefalin 1 mg Oral Tablet, Placebo Oral Tablet)
Recruiting
- Chronic Kidney Diseases
- Pruritus
- Difelikefalin 1 mg Oral Tablet
- Placebo Oral Tablet
-
Huntsville, Alabama
- +51 more
Dec 21, 2022
Carcinoma Trial (Intravenous infusion anti-CEA-CAR-T cell)
Not yet recruiting
- Carcinoma
- Intravenous infusion anti-CEA-CAR-T cell
- (no location specified)
Aug 22, 2023
Solid Tumor Trial (UCLM802 Cell Injection)
Not yet recruiting
- Solid Tumor
- UCLM802 Cell Injection
- (no location specified)
Mar 7, 2023
Solid Tumor, Adult Trial in Beijing (CD70-targeting CAR-T cells)
Recruiting
- Solid Tumor, Adult
- CD70-targeting CAR-T cells
-
Beijing, Iotherapeutic Department Of Chinsese PLA Gereral Hospital, ChinaChina
Jul 8, 2023
Using Microbiome to Predict Durvalumab Toxicity in Post-
Recruiting
- NSCLC, Stage III
- Locally Advanced Lung Carcinoma
-
Kansas City, Kansas
- +1 more
May 17, 2022
Mesothelin-positive Advanced Malignant Solid Tumors Trial in Hangzhou (UCLM802 Cell Injection (Anti-mesothelin CAR-T cells))
Recruiting
- Mesothelin-positive Advanced Malignant Solid Tumors
- UCLM802 Cell Injection (Anti-mesothelin CAR-T cells)
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital Zhejiang University School of Medi
May 11, 2023